Basic MaterialsChemicals
  • Price (EUR)144.20
  • Today's Change2.55 / 1.80%
  • Shares traded23.51k
  • 1 Year change+1.62%
  • Beta1.2701
Data delayed at least 15 minutes, as of Jun 02 2023 13:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

IMCD NV is a company based in the Netherlands that specializes in sales, marketing and distribution of specialty chemicals and foods ingredients. Its product portfolio includes chemicals from various areas, including pharmaceutics, personal care, coatings, food and nutrition, lubricants, synthesis, plastics, detergents, agrochemicals, textile, waste and water treatment, cutting and sand blasting, flavors and fragrances, oil and gas and polishing, among others. The Company operates an international supply chain with local warehouses and provides valued-added services, including repacking, dilution and blending. The Company operates worldwide.

  • Revenue in EUR (TTM)4.60bn
  • Net income in EUR313.08m
  • Incorporated1995
  • Employees4.32k
  • Location
    IMCD NVWilhelminaplein 32ROTTERDAM 3072 DENetherlandsNLD
  • Phone+31 102908684
  • Fax+31 102908680
  • Websitehttp://www.imcdgroup.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
IMCD:AEX since
Euro Chemo-Pharma Sdn BhdAnnounced19 May 202319 May 2023Announced3.18%--
KOI Products Solutions & Engineering LtdAnnounced05 May 202305 May 2023Announced6.85%--
TAGRA Biotechnologies Ltd-Import & Distribution BusinessDeal completed02 May 202302 May 2023Deal completed5.87%--
Parkash Dyechem Pvt LtdAnnounced21 Nov 202221 Nov 2022Announced5.14%--
Shanghai Sanrise Industries & Development Co LtdAnnounced31 Oct 202231 Oct 2022Announced9.04%--
Data delayed at least 15 minutes, as of Jun 02 2023 13:06 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
Oci NV8.14bn702.54m4.30bn4.06k6.152.041.960.52873.323.3238.5210.000.846212.579.982,004,763.0017.047.4627.8411.0130.6226.4820.1312.761.607.900.4634155.0853.7233.96116.90--21.75--
Clariant AG5.33bn-136.49m4.52bn11.15k--1.8625.150.8468-0.40670.249515.757.120.7864.987.15466,272.00-1.531.35-2.301.9428.7230.38-1.942.250.982232.560.3681379.7418.89-4.01-149.81---5.34-3.43
Turkiye Sise ve Cam Fabrikalari AS4.77bn809.76m5.60bn24.90k6.741.615.,281,411.0014.2612.9021.8818.9334.1334.3217.8020.921.29--0.336413.02197.4353.15113.9973.6454.0438.75
Azelis Group NV4.11bn213.19m5.66bn3.83k25.452.2818.641.380.91170.911717.5710.200.91745.788.371,074,275.004.89--6.06--23.00--5.33--0.83747.520.3705--45.34--214.65------
Arkema SA11.19bn752.00m6.17bn21.10k8.420.83984.260.55189.779.77147.0997.950.82075.916.59548,059.905.646.966.958.4020.8321.826.878.331.5914.590.328827.3121.346.77-26.6011.949.728.13
Umicore SA25.44bn569.88m6.50bn11.57k11.151.807.220.25572.372.37105.6814.642.687.5913.892,199,354.006.035.1710.168.586.506.282.251.940.7637.850.396630.445.7416.31-7.9321.545.462.71
Akron PAO1.96bn668.04m8.00bn11.21k12.147.929.834.081,562.541,562.544,595.302,395.290.73542.9921.09--25.348.4035.9812.1759.9047.3434.4615.831.10--0.448981.994.385.43-86.33-26.953.50-19.73
Imcd NV4.60bn313.08m8.07bn4.32k25.764.8219.311.755.505.5080.8329.391.336.256.961,064,421.009.056.6512.439.2622.0720.876.805.341.0413.830.362844.1833.9519.2651.0532.2910.6630.76
Evonik Industries AG18.00bn273.00m8.25bn33.92k29.980.76844.340.45820.59020.592438.5623.030.79814.748.20528,813.701.263.111.603.7321.5126.781.584.590.9947--0.29283.6423.625.15-27.94-5.44-3.620.3454
Yara International ASA20.54bn1.80bn8.81bn17.50k4.901.093.260.42984.0484.04959.45379.191.223.808.7913,967,960.0010.685.4514.697.1125.5827.098.775.891.0811.030.325268.8743.8416.05518.4942.24-7.2552.98
Chr Hansen Holding A/S1.29bn228.57m8.98bn3.69k39.225.0126.456.9412.9312.9373.18101.210.39953.236.922,608,
Novozymes A/S2.39bn487.15m10.31bn6.79k25.927.2714.974.3113.0313.0363.9646.500.66492.354.912,765,611.0013.6214.7718.8519.5354.2256.2620.4921.310.806623.910.383947.3717.403.8516.853.3411.305.92
PhosAgro PAO-1.15bn-1.15bn11.44bn25.00k--6.03----------1,277.21----------24.15--30.90--46.59--23.350.7324--0.564787.7935.4425.7242.3848.7812.2080.76
Brenntag SE19.42bn853.40m11.45bn17.50k13.422.609.240.58975.525.52125.7828.541.768.707.081,107,372.007.856.3012.148.8822.2822.404.463.901.0817.910.412935.9535.0910.5997.8119.7012.0312.70
Data as of Jun 02 2023. Currency figures normalised to IMCD NV's reporting currency: Euro EUR

Institutional shareholders

38.75%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 23 May 20235.70m10.00%
Capital Research & Management Co. (World Investors)as of 31 Mar 20233.83m6.73%
BlackRock Investment Management (UK) Ltd.as of 24 May 20232.70m4.73%
Baillie Gifford & Co.as of 25 May 20231.82m3.20%
Capital Research & Management Co. (Global Investors)as of 18 Jan 20231.73m3.03%
The Vanguard Group, Inc.as of 05 May 20231.60m2.81%
Norges Bank Investment Managementas of 31 Dec 20221.52m2.67%
Threadneedle Asset Management Ltd.as of 31 Mar 20231.15m2.01%
Jupiter Asset Management Ltd.as of 31 Jan 20231.04m1.82%
Royal London Asset Management Ltd.as of 30 Apr 2023995.55k1.75%
More ▼
Data from 31 Dec 2022 - 31 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.